Rizafilm
Product Images NDC 35781-0605

10 FDA label images from Gensco Laboratories Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Rizafilm (NDC 35781-0605). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gensco Laboratories Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of rizatriptan benzoate, showing its molecular components and arrangement as found in the active ingredient of RIZAFILM oral film.*
FDA Label Image

Figure1 (Fig1)

Figure1 (Fig1)
A line graph comparing the estimated probability of response over time between Rizatriptan Benzoate 10 mg and placebo. The x-axis represents time (units not specified), while the y-axis shows the estimated probability of response ranging from 0% to 100%. The Rizatriptan Benzoate 10 mg line shows a higher probability of response compared to placebo throughout the observed period.*
FDA Label Image

Figure2 (Fig2)

Figure2 (Fig2)
A line graph comparing the estimated probability of remediation or rescue over 24 hours post-dose between placebo and rizatriptan benzoate 10 mg. The x-axis shows hours post-dose (0 to 24), and the y-axis shows the probability percentage (0% to 100%). Two lines represent placebo and rizatriptan benzoate 10 mg, illustrating differences in response over time.*
FDA Label Image

Figure 3 (Fig3)

Figure 3 (Fig3)
A line graph showing the estimated probability of response over time (hours post-dose) comparing Rizatriptan Benzoate 10 mg film to placebo. The vertical axis represents the probability of response in percentage, ranging from 0% to 100%. The horizontal axis shows time from 0 to 2 hours post-dose. Rizatriptan Benzoate 10 mg demonstrates a higher probability of response compared to placebo at all measured time points.*
FDA Label Image

Figure 4 (Fig4)

Figure 4 (Fig4)
A line graph showing the estimated probability of remediation or rescue over 24 hours post-dose. The x-axis represents hours post-dose from 0 to 24, and the y-axis shows probability percentages from 0% to 100%. Two curves compare placebo and Rizatriptan Benzoate 10 mg, with placebo showing a higher probability throughout the time period.*
FDA Label Image

Figure5 (Fig5)

Figure5 (Fig5)
A line graph comparing the percent effect over time (hours post stage 2 dose) between rizatriptan benzoate and placebo. The x-axis shows hours (0.5 to 2.0), and the y-axis shows percent with 95% confidence intervals. Rizatriptan benzoate is represented by a solid line with filled circles; placebo is a dashed line with open circles, indicating higher percent values for rizatriptan benzoate at later time points.*
FDA Label Image

Pouch 10mg (Artwork Pouch 10mg Ver101623)

Pouch 10mg (Artwork Pouch 10mg Ver101623)
Packaging label for RIZAFILM 10 mg oral film containing rizatriptan, manufactured by Gensco Laboratories LLC. The front of the pouch shows the product name, strength, dosage form, single film count, and the Rx only designation. The back panel includes recommended storage instructions, usage directions to place the film on the tongue until it dissolves, and manufacturing details.*
FDA Label Image

Carton 10mg (Artwork Carton 10mg Ver031424)

Carton 10mg (Artwork Carton 10mg Ver031424)
Carton label for RizaFilm oral film containing 10 mg rizatriptan benzoate by Gensco Laboratories LLC. The label shows the brand name, generic name, dosage form, strength, quantity of 18 films, and the designation Rx Only. It includes storage and usage instructions alongside the NDC and GTIN codes.*
FDA Label Image

Pouch 5mg (Artwork Pouch 5mg Ver031725)

Pouch 5mg (Artwork Pouch 5mg Ver031725)
Packaging label for RIZAFLIM oral film 5 mg containing rizatriptan benzoate, presented as a single-dose film. The label includes instructions to open by folding and tearing at a notch, dosage and usage guidance, and storage temperature recommendations. The labeler is Gensco Laboratories LLC, and the product is made in Canada. The package prominently features the brand name, strength, dosage form, and a barcode.*
FDA Label Image

Carton 5mg (Artwork Carton 5mg Ver031725)

Carton 5mg (Artwork Carton 5mg Ver031725)
RizaFilm oral film 5mg packaging label by Gensco Laboratories LLC. The label prominently displays the product name RizaFilm with the active ingredient rizatriptan. The film dosage form is oral, each containing 5mg of rizatriptan. The package size indicated is 18 films. The label includes storage instructions, manufacturer information, and barcodes.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.